High-Quality Vaccine Development Powered by Quality Control Using Agilent Fragment Analyzer System

Facebook

Email

May 14, 2023

High-Quality Vaccine Development Powered by Quality Control

Testing the quality of IVT RNA and DNA products at critical points within the vaccine production keeps the development, verification, and manufacturing moving in the right direction. In this talk, Kyle Luttgeharm, product manager of automated capillary electrophoresis, presents the benefits of automated electrophoresis for reliable nucleic acid sample quality control in vaccine development workflows.

Oops! It looks like there were some errors.

Please check the highlighted fields and try again.

Download Now

login

Name *
Company/Institution *
Institution Type *
Address *
Email Address *
Work Phone Number *
Are you planning to purchase any lab products related to this content? *
I would like to be contacted by an Agilent representative by telephone or email *
Yes
No
I would like to receive updates and information about Agilent products, services, and events. For full details of how Agilent will treat your information please click here to view our privacy policy. *
Yes
No
Email & Subscription Preferences *
Topic - Specific eNewslettersNew Product Announcements and Special Offers from our trusted life science partners
Future Lab Topics
Trends in Live Cell ImagingTrends in Protein ProductionTrends in ImmunodetectionEstablishing and Maintaining a Cell Culture FacilityTrends in Flow CytometryAutomation in Drug DiscoveryTrends in Next Gen SequencingTrends in COVID-19 R&DTrends in Genomic ScreeningTrends in GenomicsAntibody-Based TherapeuticsOptimizing workflows

By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.